FDA
-
-
-
-
-
-
-
Envoy Medical to Present at Investor Conferences on June 25th
-
-
-
-
-
-
-
Envoy Medical Reaches Critical Milestone in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant
-
-
-
-
-
-
-
Envoy Medical regains Nasdaq compliance after meeting listing requirements
-
-
-
-
-
-
-
Envoy Medical closes $78 million public offering with milestone warrants
-
-
-
-
-
-
-
Envoy Medical Secures New Australian Patent for Cochlear Implant Innovation Aimed at Enhancing Input Signal-to-Noise Ratio
-
-
-
-
-
-
-
Envoy Medical Announces First Three Patients Enrolled in Final Stage of Acclaim(R) Cochlear Implant Pivotal Clinical Trial
-
-
-
-
-
-
-
Envoy Medical Receives FDA Approval to Advance Its Pivotal Clinical Trial to Final Stage Based on Submission of Promising Three-Month Data
-
326,224 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

